Title |
Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome
|
---|---|
Published in |
International Journal of General Medicine, November 2011
|
DOI | 10.2147/ijgm.s25639 |
Pubmed ID | |
Authors |
Sergio Parco, Caterina Novelli, Fulvia Vascotto, Tanja Princi |
Abstract |
The anti-Müllerian hormone (AMH) is a dimeric protein secreted by the female ovaries and has two fundamental roles in follicle genesis. It delays the entrance of the primordial follicle into the pool of follicles in growth and diminishes the sensitivity of the ovarian follicle towards follicle-stimulating hormone (FSH). The purpose of this work was to study the AMH (nv 2.0-6.8 ng/mL) as a marker during assisted reproductive technology (ART), in order to identify cases of infertility due to polycystic ovarian syndrome (PCOS). This syndrome affects 10% of women with infertility problems, and a new biological marker could be useful to general practitioners of internal medicine to help generate the suspicion of PCOS so that they can refer the patient to the gynecologist for confirmation. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 26 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 19% |
Student > Doctoral Student | 4 | 15% |
Researcher | 4 | 15% |
Other | 2 | 8% |
Professor | 1 | 4% |
Other | 2 | 8% |
Unknown | 8 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 31% |
Biochemistry, Genetics and Molecular Biology | 4 | 15% |
Agricultural and Biological Sciences | 3 | 12% |
Psychology | 1 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Other | 0 | 0% |
Unknown | 9 | 35% |